SEARCH

SEARCH BY CITATION

References

  • Avrameas S. (1969) Coupling of enzymes to proteins with glutaraldehyde. Use of conjugates for the detection of antigens and antibodies. Immunochem. 1, 4352.
  • Avrameas S. and Ternynck T. (1971) Peroxidase labeled antibody and Fab conjugates with enhanced intracellular penetration. Immunochem. 12, 11751179.
  • Berry M.D. (2004) Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators. J. Neurochem. 90, 257271.
  • Campistron G., Geffard M. and Buys R.M. (1986) Immunological approach to the detection of taurine and immunocytochemical results. J. Neurochem. 46, 862868.
  • Cooper J. R., Bloom F. E. and Roth R. H. (2003) The Biochemical Basis of Neuropharmacology. Oxford University Press, New York.
  • Dabadie H. and Geffard M. (1993) Identification of tryptamine and tryptamine-serotonin neurons in the rat dorsal raphe nuclei using specific antibodies. Synapse 14, 178183.
  • Davis B. A. (1989) Biogenic amines and their metabolites in body fluids of normal, psychiatric and neurological subjects. J. Chromatogr. 466, 89218.
  • Eisenhofer G., Kopin I. J. and Goldstein D. S. (2004) Catecholamine metabolism: a contemporary view with implications for physiology and medicine. Pharmacol. Rev. 56, 331349.
  • Fuchs S. and Sela M. (1963) Studies on the chemical basis of the antigenicity of proteins. Biochem. J. 87, 7079.
  • Fujiwara K., Murata I., Yagisawa S., Tanabe T., Yabuuchi M., Sakakibara R. and Tsuru D. (1999) Glutaraldehyde (GA) – hapten adducts, but without a carrier protein, for use in a specificity study on an antibody against a GA-conjugated hapten compound: histamine monoclonal antibody (AHA-2) as a model. J. Biochem. 126, 11701174.
  • Geffard M., Dulluc J. and Rock A. M. (1985) Antisera against the indolealkylamines: trytophan, 5-hydroxytryptophan, 5-hydroxytryptamine, 5-methoxytryptophan, and 5-methoxytryptamine tested by an enzyme-linked immunosorbent assay method. J. Neurochem. 44, 12211228.
  • Habeeb A. F. S. A. and Hiramoto R. (1968) Reaction of proteins with glutaricaldehyde. Arch. Biochem. Biophys. 126, 1626.
  • Harthé C., Claustrat B., Brun J and Chazot G. (1991) Direct radioimmunoassay of 6 sulfatoxymelatonin in plasma with use of an iodinated tracer. Clin. Chem. 37/4, 536539.
  • Heacock R. A. and Hutzinger O. (1968) Chemistry of the aminochromes. Part XII. Some new aminochromes and their derivatives. Can. J. Chem. 47, 20092013.
  • Hermanson G. T. (2008) Bioconjugate Techniques, 2nd edn. Academic Press-Elsevier, Amsterdam.
  • Herzenberg L. A. and Tokuhisa T. (1962) Epitope-specific regulation I. carrier-specific induction of suppression for IgG anti-hapten antibody response. J. Exp. Med. 135, 17301740.
  • Herzenberg L. A., Tokuhisa T., Parks D. and Herzenberg L. A. (1982) Epitope-specific regulation II. A bistable, Igh-restricted regulatory mechanism central to immunologic memory. J. Exp. Med. 135, 17411753.
  • Hodgson A. J., Penke B., Erdei A., Chubb I. W. and Somogyi P. (1985) Antisera to GABA. J. Histochem. Cytochem. 33, 229239.
  • Karasawa N., Isomura G. and Nagatsu I. (1992) Production of specific antibody against L-Dopa and its ultrastructural localization of immunoreactivity in the house shrew (Suncus murinus) lateral habenular nucleus. Neurosci. Lett. 143, 267270.
  • Kema I. P., De Vries E. G. and Muskiet F.A. (2000) Clinical chemistry of serotonin and metabolites. J. Chromatogr. B. 747, 3348.
  • Khor S-P. and Hsu A. (2007) The pharmaconetics and pharmacodynamics of levodopa in the treatment of Parkinson’s disease. Curr. Clin. Pharmacol. 2, 234243.
  • Kim J., Jeon M., Paeng K. J. and Paeng I. (2008) Competitive enzyme-linked immunosorbent assay for the determination of catecholamine, dopamine in serum. Anal. Chim. Acta 619, 9793.
  • Kuoppamäki M., Korpela K., Martilla R. et al. (2009) Comparison of pharmacokinetic profile of levodopa throughout the day between levodopa/carbidopa/entacapone and levodopa/carbidopa when administered four or five times daily. Eur. J. Clin. Pharmacol. 65, 443455.
  • Kuznetsova N. P., Pisarev O. A., Mishaeva R. N. and Gudkin L. R. (2003) Thermodynamics of oligomerization of glutaric aldehyde with amino acids. Russian J. Appl. Chem. 76, 17981802.
  • Landsteiner K. (1945) The Specificity of Serological Reactions. Harvard University Press, Cambridge, MA.
  • Lapin I. (2001) Phenibut (β-Phenyl-GABA): a tranquilized and nootropic drug. CNS Drug Rev. 7, 471481.
  • Luther P. W. and Bloch R. J. (1989) Formaldehyde-amine fixatives for immunocytochemistry of cultured xenopus myocytes. J. Histochem. Cytochem. 37, 7582.
  • Mauerer P. H. (1964) Antigenicity of polypeptides (Poly alpha amino acids): XII. immunological studies with synthetic polymers containing only D- or D- and L-alpha-amino acids. J. Exp. Med. 125, 339349.
  • McDevitt H. O. and Sela M. (1967) Genetic control of the antibody response II Firther Analysis of the Specificity of determinant-specific control, and genetic analysis of the response to (H,G)-A-L in CHA and C57 mice. J. Exp. Med. 126, 969978.
  • Meyer K., Behringer D. M. and Veh R. W. (1991) Antibodies against neuroactive aminoacids and neuropeptides. I. A new two-step procedure for their conjugation to carrier proteins and the production of an anti-met-enkephalin antibody reactive with glutaric aldehyde-fixed tissues. J. Histochem. Cytochem. 39, 749760.
  • Minami M., Takahashi H., Inagaki H., Yamano Y., Onoue S., Matsumoto S., Sasaki T. and Sakai K. (2009) Novel tryptamine-related substances, 5-sulphatoxydiacetyltryptamine, 5-hydroxydiacetyltryptamine, and reduced melatonin in human urine and the determination of those compounds, 6-sulphatoxymelatonin, and melatonin with fluorometric HPLC. J. Chromatogr. B 877, 814822.
  • Mons N. and Geffard M. (1987) Specific antibodies against catecholamines: L-3,4 dihydroxyphenylalanine, dopamine, noradrenaline, and octopamine tested by an enzyme-linked immunosorbent assay. J. Neurochem. 48, 18261833.
  • Pedersen M. K., Sorensen N. S., Heegaard P. M. H., Beyer N. H. and Bruun L. (2006) Effect of different hapten-carrier conjugation ratios and molecular orientations on antibody affinity against a peptide antigen. J. Immunol. Meth. 311, 198206.
  • Peters T. (1995) All About Albumin: Biochemistry, Genetics and Medical Applications. Academic press Inc., San Diego, CA.
  • Schwartz M., Parhami B., Mozes E. and Sela M. (1979) Change in specificity of antibodies to a random synthetic branched polypeptide in mice tolerant to its ordered analogs. Proc. Natl Acad. Sci. USA 76, 52865288.
  • Seguela P., Geffard M., Buys R. M. and Moal le M. (1984) Antibodies against gamma aminobutyric acid: specificity studies and immunocytochemical results. Proc. Natl Acad. Sci. USA 81, 38883892.
  • Singh K. V., Kaur J., Varshney G. C., Raje M. and Suri R. (2004) Synthesis and characterization of hapten-protein carrier for antibody production against small molecules. Bioconjugate Chem. 15, 168173.
  • Smythies J. and Galzigna L. (1998) The oxidative metabolism of catecholamines in the brain: a review. Biochem. Biophys. Acta, 1380, 159162.
  • Turner E. H., Loftis J. M and Blackwell A. D. (2006) Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan. Pharm. Ther. 109, 325338.
  • Vandenabeele-Trambouze O., Geffard M., Bodet D., Despois M., Dobrijevic M., Loustalot M. F. and Commeyras A. (2002) Antibodies directed against L and D isovaline using a chemical derivatizing reagent for the measurement of their enantiomeric ratio in extraterrestrial samples: first step production and characterization of antibodies. Chirality. 14, 519526.
  • Weston P. D. and Avrameas S. (1971) Proteins coupled to polyacrylamide beads using glutaraldehyde. Biochem. Biophys. Res. Commun. 45, 15741580.